Hypersensitivity reactions during treatment with infliximab, etanercept, and adalimumab

Annals of Allergy, Asthma and Immunology

Volumn 108, Issue 2, 2012, Pages 123-124

  Puxeddu, Ilaria ^a   Giori, Lucia ^a   Rocchi, Valeria ^a   Bazzichi, Laura ^a   Bombardieri, Stefano ^a   Tavoni, Antonio ^a   Migliorini, Paola ^a   Del Corso, Isabella ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB;

ADULT; AGED; ANGIONEUROTIC EDEMA; ANKYLOSING SPONDYLITIS; AUTOIMMUNE DISEASE; BEHCET DISEASE; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC VALUE; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LETTER; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRICK TEST; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SKIN ANAPHYLAXIS; SPONDYLOSIS; SYSTEMIC DISEASE; URTICARIA;

EID: 84856502972     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2011.11.004     Document Type: Article

References (8)

1. C. Scheinecker, K. Redlich, J.S. Smolen Cytokines as therapeutic targets: advances and limitations Immunity 28 2008 440 444 (Pubitemid 351467046)
2. J.A. Gomez-Puerta, R. Sanmarti, J.R. Rodriguez-Cros, J.D. Caete Etanercept is effective in patients with rheumatoid arthritis with no response to infliximab therapy Ann Rheum 63 2004 896 (Pubitemid 38850474)
3. R. Maini, E.W. St Clair, F. Breedveld Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial ATTRACT Study Group Lancet 354 1999 1932 1939
4. M.E. Weinblatt, E.C. Keystone, D.E. Furst Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial Arthritis Rheum 48 2003 35 45 (Pubitemid 36091645)
5. M. Benucci, M. Manfredi, G. Saviola, P. Baiardi, P. Campi Correlation between atopy and hypersensitivity reactions durino therapy with three different TNF-alpha blocking agents in rheumatoid arthritis Clin Exp Rheumatol 27 2009 333 336
6. F.E. Simons, L.R. Ardusso, M.B. Bil World Allergy Organization anaphylaxis guidelines: summary J Allergy Clin Immunol 127 2011 587 593
7. A. Vultaggio, A. Matucci, F. Nencini Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions Allergy 65 2010 657 661
8. A. Vultaggio, A. Matucci, F. Nencini, S. Pratesi, E. Maggi Skin testing and infliximab-specific antibodies detection as a combined strategia for preventing infusion reaction Intern Emerg Med 2011 [Epub ahead of print]